# Lipid metabolism and osteonecrosis: unraveling causal mechanisms via multi-omics and mendelian randomization

**Authors:** Ying Chen, Zihong Zhou, Hui Che, Ding Li

PMC · DOI: 10.3389/fphys.2025.1642153 · Frontiers in Physiology · 2025-10-23

## TL;DR

This study explores how lipid metabolism and osteonecrosis are causally linked using genetic and multi-omics data, identifying key genes and lipid species involved.

## Contribution

The study establishes bidirectional causal relationships between lipid metabolism and osteonecrosis using Mendelian randomization and experimental validation.

## Key findings

- Four lipid species were found to have protective effects against osteonecrosis.
- Osteonecrosis induces a 'lipid storm,' increasing 25 circulating lipid species.
- Genes APOE, PRKCA, and ALK were confirmed as dysregulated in osteonecrotic cartilage.

## Abstract

Osteonecrosis (ON), a debilitating condition marked by ischemic bone death, has been clinically linked to dysregulated lipid metabolism, yet the causal relationships and underlying genetic mechanisms remain poorly defined. This study employed bidirectional Mendelian randomization (MR) analyses using genome-wide association study (GWAS) datasets to investigate causal effects between 179 plasma lipid species and ON. Functional enrichment and protein-protein interaction (PPI) analyses were conducted to identify key genes, followed by transcriptomic validation using public datasets and experimental confirmation through qRT-PCR and immunohistochemistry. MR analysis revealed that four lipid species had protective effects against ON, while two were associated with increased risk. Conversely, ON itself was found to induce a significant “lipid storm,” elevating 25 circulating lipid species, including phosphatidylcholines and triacylglycerols. PPI network analysis identified key regulatory hubs, with transcriptomic and experimental validation confirming significant dysregulation of APOE, PRKCA and ALK in osteonecrotic cartilage. These findings establish a bidirectional causal link between lipid dysregulation and ON and highlight novel molecular targets that may inform future therapeutic strategies.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348], PRKCA (protein kinase C alpha) [NCBI Gene 5578], ALK (ALK receptor tyrosine kinase) [NCBI Gene 238]
- **Diseases:** osteonecrosis (MONDO:0005380)

## Full-text entities

- **Genes:** PRKCA (protein kinase C alpha) [NCBI Gene 5578] {aka AAG6, PKC-alpha, PKCA, PKCI+/-, PKCalpha}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}
- **Diseases:** ischemic bone death (MESH:D003643), lipid storm (MESH:D011017), ON (MESH:D010020)
- **Chemicals:** phosphatidylcholines (MESH:D010713), triacylglycerols (MESH:D014280), Lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12589827/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12589827/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12589827/full.md

---
Source: https://tomesphere.com/paper/PMC12589827